# HC Scientific Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hc-scientific-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Chengdu, China
- Website: www.hcsci.com
- Total disclosed funding: $72M
- Latest round: Series B (Aug 28, 2023)
- Investors on record: 13

## About

Established in 2016 and based in Chengdu, China, HC Scientific Technology Co., Ltd. is a medical company that focuses on the realm of life sciences. In August 2023, HC Scientific Technology Co., Ltd. raised more than CNY 300 million in series B+ funding co-led by new investors GTJA Innovation Investment and Lake Bleu Capital.

The company's products include a high-throughput genotyping system, a fully automated multi-functional genetic testing system, high throughput automated nucleic acid extraction platform, etc. The products can be applied in modern agriculture, health management, technological livestock, and biological breeding. It has also developed an automated dispensing platform that can complete the addition of 384 test samples and electrophoresis-related reagents within 24 minutes. It can be used in SSR labeling detection, sample quality monitoring, and other fields.

The company will use the funds for new product development, market expansion, overseas business development, and team building in the fields of bio-breeding and life science and technology.

## Funding rounds

- Series B, Aug 28, 2023, $41M — Legend Capital, GTJA Innovation Investment, LYFE Capital, Dalton Venture, Lake Bleu Capital, BIO-TOWN Capital, Eightfold Venture Partners, Hubei Fengze Private Equity Fund Management
- Series B, Sep 1, 2021, $31M — Legend Capital, NLVC, Sinovation Ventures, LYFE Capital, BioTrack Capital, Yunzhi Capital
- Series A, Mar 24, 2020 — NLVC, Fosun International, BioTrack Capital, Yunzhi Capital
- Series B, Feb 26, 2019 — NLVC
- Series A, Jul 25, 2018 — Fosun International, BioTrack Capital

## Investors

- Fosun International (https://capitalatlas.ai/funds/fosun-international) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A, Series B
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series B, Series A
- Yunzhi Capital — Series A, Series B
- Legend Capital — Series B
- Sinovation Ventures (https://capitalatlas.ai/funds/sinovation-ventures) — Series B
- LYFE Capital — Series B
- GTJA Innovation Investment (https://capitalatlas.ai/funds/gtja-innovation-investment) — Series B
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series B
- Lake Bleu Capital (https://capitalatlas.ai/funds/lake-bleu-capital) — Series B
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Series B
- Eightfold Venture Partners — Series B
- Hubei Fengze Private Equity Fund Management — Series B